INTRODUCTION
As an important member of the carbapenemase, metallo-blactamase (MBL) hydrolyses almost all b-lactams. Generally, the popular MBLs have been widespread in non-fermenting Gram-negative bacilli, including Pseudomonas aeruginosa, Acinetobacter spp. and rarely detected Enterobacteriaceae (Nordmann et al., 2012; Tzouvelekis et al., 2012) . The situation has changed since the emergence and the worldwide dissemination of New Delhi MBL 1 (NDM-1)-producing Enterobacteriaceae (NPE) in both humans and the environment (Kumarasamy et al., 2010) . Enterobacteriaceae are important pathogens causing severe infections, including bloodstream infections, intra-abdominal infections and urinary tract infections. Therefore, the emergence and prevalence of bla NDM-1 among various Enterobacteriaceae are clinically important.
In China, several NDM-1-producing enterobacterial species have been identified (Ho et al., 2012; Wang et al., 2014 Wang et al., , 2015 Yang et al., 2014; Zhou et al., 2014; Jin et al., 2015; Qu et al., 2015; Zhang et al., 2015; Zhu et al., 2015 Zhu et al., , 2016 Zheng et al., 2016) . The most prevalent species are Klebsiella pneumoniae, Klebsiella oxytoca, Escherichia coli, Enterobacter cloacae, Enterobacter aerogenes and Citrobacter freundii. In addition, some uncommon enterobacterial species, such as Morganella morganii , Providencia rettgeri (Zhou et al., 2014) , Raoultella ornithinolytica (Zhou et al., 2014; Sun et al., 2015) , Raoultella planticola , Leclercia adecarboxylata and Proteus mirabilis , have also been found carrying bla NDM . Since 2012, various sequence types (STs) of K. pneumoniae, Escherichia coli and Enterobacter cloacae have been confirmed carrying bla NDM , such as K. pneumoniae STs 11, 15, 17, 20, 37, 76, 105, 113, 147, 433, 476, 483, 889, 966, 1031 and 1240 (Ho et al., 2012 Hu et al., 2013; Qin et al., 2014; Wang et al., 2014 Wang et al., , 2015 Zhou et al., 2014; Jin et al., 2015; Zhang et al., 2015; Zheng et al., 2016; Zhu et al., 2016) , Escherichia coli STs 40, 101, 167, 205, 224, 361, 410, 744 and 1237 (Ho et al., 2012; Liu et al., 2013; Qin et al., 2014 Qin et al., , 2015 Yang et al., 2014; Zhou et al., 2014; Wang et al., 2015) and Enterobacter cloacae STs 41, 66, 88, 90, 93, 114, 120 and 190 (Liu et al., 2015; Wang et al., 2015) . The majority of bla NDM -carrying plasmids belong to X3 and A/ C incompatibility types, while IncN, IncN2, IncFI, IncFIB, IncFII Y , IncH, IncHI2 and IncI1 plasmids with various sizes have also been detected (Ho et al., 2012; Li et al., 2014; Qin et al., 2014; Zhou et al., 2014; Liu et al., 2015; Sun et al., 2015; Yang et al., 2015; Zheng et al., 2016) .
From 2009 to 2013, five NPE isolates (one K. pneumoniae, one Escherichia coli, one Enterobacter cloacae, one Providencia rettgeri and one R. ornithinolytica) have been identified in our hospital (Zhou et al., 2014) . Recently, further surveillance on the prevalence of NPE was conducted in carbapenem-resistant Enterobacteriaceae (CRE). Although NPE exhibited sporadic prevalence in our hospital, several novel NDM-producing K. pneumoniae and Escherichia coli clones (with novel STs) were identified. Furthermore, we found that an Escherichia coli strain had acquired a bla NDM-1 -carrying plasmid in vivo. Phenotypic and genotypic characteristics of the NPE isolates were further analysed.
METHODS
Identification, antimicrobial susceptibility and carbapenemase gene determination of bacterial isolates. All clinical enterobacterial isolates were collected from a 4000-bed tertiary-care hospital in Beijing and were identified by VITEK ® MS (bioM erieux SA). The isolates that exhibited non-susceptibility to carbapenems were screened for bla NDM , bla IMP , bla VIM , bla KPC and bla OXA-48 by PCR and sequenced as previously described by Zhou et al. (2014) . Escherichia coli ATCC 25922 was used as the quality control strain for antimicrobial susceptibility testing. The Salmonella ser. Braenderup strain H9812 was used as a reference standard for PFGE. Sodium-azide-resistant Escherichia coli J53 was used as the recipient for conjugation testing. No ethical approval was obtained for using the clinical samples because they were collected during routine bacteriologic analyses in public hospitals, and the data were anonymously analysed.
Antimicrobial susceptibility testing. The MICs for cefotaxime, cefepime, piperacillin-tazobactam, imipenem, meropenem, ertapenem, amikacin and levofloxacin were measured by Etest (AB bioM erieux). Results were interpreted according to the interpretive standards of the Clinical Laboratory Standards Institute (CLSI, 2014) .
PFGE and multilocus sequence typing analysis. PFGE with XbaI or SfiI (for Providencia rettgeri) was performed for carbapenemase-producing isolates as previously described by Yang et al. (2013) . Multilocus sequence typing (MLST) was carried out for Escherichia coli, K. pneumoniae and Enterobacter cloacae according to protocols provided on their MLST websites (http://mlst.ucc.ie/mlst/dbs/Ecoli, http://www.pasteur.fr/ recherche/genopole/PF8/mlst/Kpneumoniae and http://pubmlst.org/ ecloacae/, respectively).
Plasmid and Southern blot analysis. The transferability of plasmids was identified by conjugation experiments (Yang et al., 2013) . The transferable plasmid DNA was extracted from the transconjugants using the Qiagen Plasmid Midi Kit (Qiagen). For clinical isolates carrying nontransferable plasmids, S1-PFGE was performed to isolate the plasmids and to confirm the sizes of the plasmids. Then, the DNA fragment was excised from the agarose gel using a clean and sharp scalpel. About 1.2 to 3.0 mm 3 of agarose gel with the DNA fragment was added into a 50 µl PCR mixture as the template for PCR amplification. The plasmids were analysed using several simplex and multiplex PCR assays for their incompatibility types (Johnson et al. 2007 (Johnson et al. , 2012 . A bla NDM probe was generated by labelling the PCR product using the PCR DIG Probe Synthesis Kit (Roche Applied Sciences). S1-PFGE and Southern blot analyses were performed as previously described by Yang et al. (2013) .
RESULTS
Prevalence of NPE and acquisition of bla NDM-1 -carrying plasmid in vivo Between 2014 and 2015, 51 NPE isolates were identified in our hospital, including 22 Escherichia coli, 10 K. pneumoniae, 9 Enterobacter cloacae, 2 Enterobacter aerogenes, 3 Providencia rettgeri, 1 K. oxytoca, 1 Proteus mirabilis, 1 C. freundii, 1 C. werkmanii and 1 R. planticola. The 51 NPE isolates were recovered from 49 patients in our hospital. The sources of the NDM-producing enterobacterial isolates included 19 urine, 18 drain, 5 bile, 7 sputum, 1 blood and 1 catheter samples (Table 1) . From September 2014 to January 2015, three Escherichia coli isolates that belonged to the same PFGE type (C9) were isolated from a patient. The first isolate was carbapenem susceptible, whereas the latter two isolates exhibited high-level resistance to carbapenems (Table 2 ). Further analysis showed that the resistant isolates acquired a bla NDM-1 -carrying plasmid during infection ( Fig. 1 ).
Genetic relatedness of NPE
The 22 Escherichia coli isolates were categorized into 17 PFGE types. In total, four Escherichia coli isolates belonged to PFGE type C5, while only two isolates belonged to types C8 and C9, respectively (Table 1) . Eight PFGE types of K. pneumoniae have been identified. Among the nine Enterobacter cloacae isolates, four belonged to type E2, while the other five isolates belonged to five different types (Table 1) . Providencia rettgeri type P1 was isolated in October 2012 for the first time (Zhou et al., 2014) and was subsequently isolated from another two patients between 2014 and 2015.
Antimicrobial susceptibility
The antimicrobial susceptibility patterns of the isolates are listed in Table 1 . All isolates presented resistance to bla NDM variants PCR and amplicon sequence alignment revealed that most strains carried bla NDM-1 , and several bla NDM gene sequences displayed 100 % identity with the published sequences of the bla NDM-4 , bla NDM-5 and bla NDM-9 genes (Table 1) .
MLST
For Escherichia coli, K. pneumoniae and Enterobacter cloacae, diverse STs were identified (Table 1) . Five Escherichia coli strains belonged to ST167, while three novel STs (ST5836, ST5837 and ST5838) with the allelic profile 429-321-33-26-11-8-6, 429-556-12-1-20-18-7 and 43-11-216-18-10-8-6, respectively, have also been identified. For K. pneumoniae, three novel STs were identified with the allelic profile 2-1-99-1-9-5-5, 4-4-1-1-7-114-10 and 2-31-154-69-1-94-140, respectively. Three Enterobacter cloacae strains were characterized as ST182, and Enterobacter cloacae STs 262, 270 and 544 were also identified (Table 1) .
Plasmid analysis
The bla NDM genes were carried by plasmids with sizes ranging from approximately 30 to 300 kb. Five incompatibility types of bla NDM -carrying plasmids were identified including X3, A/C, B/O, N and Frep. In total, 25 NPE strains carried the IncX3 plasmids with sizes ranging from 30 to 50 kb, while 70 to 300 kb IncA/C bla NDM -carrying plasmids were found in 11 NPE strains (Table 1) . IncB/O bla NDM -carrying plasmids were detected in six NPE strains. Five strains were found harbouring multiple bla NDM -carrying plasmids with different sizes or incompatibility types (Table 1) .
DISCUSSION
In total, 7064 enterobacterial isolates have been collected during 2014 to 2015 in our hospital, and 397 (5.62 %) of them exhibited carbapenem-resistant phenotypes. Among these CRE isolates, 51 NPE (12.8 %) have been identified. Compared with other CRE such as KPC-2-producing K. pneumoniae which had been continuously spread in China (Yang et al., 2013; Zhou et al., 2015) , NPE presented low prevalence.
In this study, 22 (43.1 %) of the 51 NPE isolates were Escherichia coli, the majority of which were genetically unrelated strains. Only one outbreak covering four patients was caused by NDM-5-producing Escherichia coli ST167 (type C5). Meanwhile, another four Escherichia coli strains (C1, C8, C14 and C15) belonged to ST167, and three of them also produced NDM-5 (Table 1) . Therefore, NDM-5-producing Escherichia coli ST167 may have some advantages in transmission, and it has also been observed in other hospitals in China Chen et al., 2016) . Four strains produced NDM-1, NDM-4, NDM-5 and NDM-9 and were identified as new clones with novel STs (Table 1) , suggesting the clonal diversity of NDM-producing Escherichia coli. For K. pneumoniae and Enterobacter cloacae, only outbreaks at small scales were observed and covered only three or four patients. Most strains exhibited distant genetic relationships. Furthermore, all eight types of NDM-producing K. pneumoniae belonged to eight different STs, and four STs were identified among six bla NDM-1 -carrying Enterobacter cloacae strains (Table 1) . Other reports from China also showed that the STs of NDM-producing Escherichia coli, K. pneumoniae and Enterobacter cloacae are highly dispersed (Ho et al., 2012; Hu et al., 2013; Liu et al., 2013 Liu et al., , 2015 Qin et al., 2014 Qin et al., , 2015 Wang et al., 2014 Wang et al., , 2015 Yang et al., 2014; Zhou et al., 2014; Jin et al., 2015; Qu et al., 2015; Zhang et al., 2015; Zhu et al., 2015 Zhu et al., , 2016 Zheng et al., 2016) . Thus, the NPE isolates exhibited a significant sporadic prevalence across the country. Under the same medical conditions and selective pressure, some CRE strains (e.g. KPC-2-producing K. pneumoniae) spread throughout the hospital (Yang et al., 2013) . However, the NPE strains only exhibited low prevalence and small scale of outbreaks. It has been reported that some biological characteristics, such as cell motility, secretion, DNA repair and modification, may contribute to the rapid spread of some specific clones (e.g. KPC-producing K. pneumoniae ST258 and ST11) (Chmelnitsky et al., 2013) . More studies are required to reveal the genetic background of the pathogenic and transmission abilities of these NPE isolates.
In China, the majority of NPEs were K. pneumoniae, K. oxytoca, Escherichia coli, Enterobacter cloacae, Enterobacter aerogenes and C. freundii (Ho et al., 2012; Wang et al., 2014 Wang et al., , 2015 Yang et al., 2014; Zhou et al., 2014; Jin et al., 2015; Qu et al., 2015; Zhang et al., 2015; Zhu et al., 2015 Zhu et al., , 2016 Zheng et al., 2016) . Meanwhile, some uncommon NDM-producing enterobacterial isolates, such as M. morganii, Providencia rettgeri, R. ornithinolytica, R. planticola, L. adecarboxylata and Proteus mirabilis, have also been identified across the country Zhou et al., 2014; Qin et al., 2015; Sun et al., 2015; Wang et al., 2015) . In this study, an NDM-producing C. werkmanii was isolated in July 2015 from a bile sample and possessed a bla NDM-1 -carrying IncX3 plasmid with a size of about 100 kb ( Table 1) . As far as we know, this is the first report of bla NDM-1 -carrying C. werkmanii worldwide.
IncX plasmids are thought to be narrow-host-range plasmids of Enterobacteriaceae and are low in prevalence (Johnson et al., 2012; Yang et al., 2014) . However, the majority (26/45) of bla NDM -carrying plasmids analysed in this study belonged to IncX3, which had almost the same size (~50 kb) and were detected in almost all NPE species (Table 1) . Other studies from China have also shown that the most common plasmid Inc type to harbour bla NDM is IncX3 (Ho et al., 2012; Wang et al., 2014; Yang et al., 2014 Yang et al., , 2015 Zhou et al., 2014; Chen et al., 2016) , indicating that the main manner mediating the transfer of bla NDM may be the spread of IncX3 plasmids in China. Furthermore, the sequence of bla NDM -harbouring IncX3 from China was almost identical to the plasmid isolated from India (Chen et al., 2016) , suggesting the possible source of this plasmid. In Europe and India, the most common bla NDM -carrying plasmid Inc type is IncA/C (Wailan & Paterson, 2014) , which has also been detected in some areas in China (Qin et al., 2014a; Liu et al., 2015) . Our previous studies confirm that the bla NDM-1 -harbouring IncA/C plasmids have already emerged in Escherichia coli and Providencia rettgeri since October 2012 (Zhou et al., 2014) . In this study, the IncA/C plasmids were the second most common plasmids, and 11 of the 45 bla NDM -carrying plasmids belonged to this type, with sizes ranging from 70 to 300 kb (Table 1) . IncA/C plasmids are thought to be vehicles that have an extremely broad bacterial host range (Wailan & Paterson, 2014) and, therefore, may play an important role in the spread of bla NDM in China. In this study, some isolates harboured two types of bla NDM -carrying plasmids simultaneously, e.g. IncX3 and IncB/O in Escherichia coli and K. pneumoniae, IncA/C and IncB/O in Enterobacter cloacae and IncX3 and IncA/C in R. planticola (Table 1) , indicating the active state and effective capacity of clinical isolates to acquire the resistant plasmids. In addition, an Escherichia coli strain (type C9) developed carbapenem resistance in vivo by acquiring a 140 kb bla NDM-1 -carrying IncFrep plasmid ( Fig. 1 ; Tables 1  and 2 ). More studies are needed to clearly identify how the patient most likely acquired the bla NDM -carrying plasmid. The transfer of bla NDM-1 -carrying plasmid in vivo has been observed among clinical K. pneumoniae isolates (Zhu et al., 2015) . Although the current NPE strains had no advantage in dissemination in hospital, the inter-strain transmission of resistant plasmids contributed significantly to the spread of the bla NDM determinants. Of particular note was that the IncX3 and IncA/C plasmids with various sizes might have emerged as the main platforms mediating the spread of bla NDM genes in China.
However, the present study had the following limitations. First, as a retrospective analysis with limited patient information, this study focused only on the phenotypic and genotypic characteristics of the clinical NPE isolates, without considering the patients' clinical features. Second, other resistance-related determinants of NPE and the genetic environment of bla NDM genes remained to be characterized in our future study.
